Trial in Progress: QUINTESSENTIAL—a Phase 2 study of Arlocabtagene Autoleucel (arlo-cel) in Patients with relapsed/refractory Multiple Myeloma (RRMM)

20260 citationsJournal Article

Authors

Partnerships for the goals

Published in: Transplantation and Cellular Therapy

Volume 32, Issue 2, pp. S205-S205

Field-Weighted Citation Impact: 0.00